Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Research · November 24, 2022

Levetiracetam vs Fosphenytoin as a Second-Line Drug After Diazepam Therapy for Adult Convulsive Status Epilepticus

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Neurology, Neurosurgery, and Psychiatry
Levetiracetam versus fosphenytoin as a second-line treatment after diazepam for adult convulsive status epilepticus: a multicentre non-inferiority randomised control trial
J. Neurol. Neurosurg. Psychiatr. 2022 Oct 07;[EPub Ahead of Print], K Nakamura, A Marushima, Y Takahashi, M Mochizuki, A Kimura, Y Fukuda, M Asami, H Nakamoto, S Egawa, J Kaneko, K Unemoto, Y Kondo, C Yonekawa, M Uchida, E Hoshiyama, T Yamada, K Maruo, E Ishikawa, Y Matsumaru, Y Inoue

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading